<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-viruses-11-00252">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Matsuyama</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kimura</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kitagawa</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Pfeffer</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kawakami</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Watanabe</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Kundig</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Amakawa</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kishihara</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wakeham</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development</article-title>
  <source>Cell</source>
  <year>1993</year>
  <volume>75</volume>
  <fpage>83</fpage>
  <lpage>97</lpage>
  <pub-id pub-id-type="doi">10.1016/S0092-8674(05)80086-8</pub-id>
  <pub-id pub-id-type="pmid">8402903</pub-id>
 </element-citation>
</ref>
